BioSpace News Archive

Your workplace habits can interfere with your work life and cause professional imbalance. Therefore, you should avoid these habits to boost your productivity.

Venous leg ulcer Phase 2 trial on track: top-line results mid-November

Johnson & Johnson today announced that it has completed the divestiture of its LifeScan business to Platinum Equity for approximately $2.1 billion.

Omnipod System to be Highlighted at the 54th Annual Meeting of the European Association for the Study of Diabetes in Berlin, Germany

PharmAbcine, Inc. announces that the company received “Study May Proceed Letter “ from the US Food and Drug Administration (FDA) for the Investigational New Drug (“IND”) application of its flagship antibody, TTAC-0001.

EpiVax, Inc. announced today that they have been awarded a two-year $1 million contract from the Food and Drug Administration (FDA) in response to a Broad Agency Announcement (BAA), FDA BAA-17-00123.

Data reinforce importance of early initiation and continuation of OCREVUS treatment

Transgene will be presenting three posters highlighting the Company’s world-leading viral vector expertise and their potential to transform the fight against cancer at the annual meeting of the Society for Immunotherapy of Cancer (SITC) to be held November 7-11 in Washington DC (USA).

Nordic Nanovector ASA announces that an abstract reporting data from the Phase 1/2a LYMRIT 37-01 study investigating Betalutin® (177Lu-lilotomab satetraxetan) in patients with relapsed/refractory indolent non-Hodgkin’s lymphoma (iNHL) has been accepted for a poster presentation at the 60th Annual Society of Hematology (ASH) Annual Meeting & Exposition (1-4 December 2018, San Diego, CA).

Dr. Reddy’s Laboratories Ltd. announced today that its wholly owned subsidiary Promius Pharma, LLC, has sold its rights of Cloderm® (clocortolone pivalate) Cream, 0.1% and its authorized generic to EPI Health, LLC, an affiliate of EPI Group, LLC.